Skip to main content
Caplight Logo









Amplexd Therapeutics

Amplexd Therapeutics

Private
Gaithersburg, MarylandHealthcare & Life Scienceshttps://amplexd.com

Last Round

Seed

May 20, 2024

Total Funding Raised

$2M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Amplexd Therapeutics operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a Seed round in May 2024.

Amplexd Therapeutics is a biotechnology company that develops non-invasive, accessible therapies for HPV-induced cervical intraepithelial neoplasia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Amplexd Therapeutics Comparables

Compare Amplexd Therapeutics with similar companies based on industry and business-model similarity.

Amplexd Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Antiva Biosciences
84%
Frantz Medical Group
82%
Gynion
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Amplexd Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 20, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 681% MoM, reaching 1.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Amplexd Therapeutics Filings

Explore SEC and related filing metadata, where available.

Amplexd Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Amplexd Therapeutics's valuation, stock price, and market status.

Is Amplexd Therapeutics a public or private company?

Amplexd Therapeutics is a private company.

What is the current stock price of Amplexd Therapeutics?

Amplexd Therapeutics is a private company, so its shares have no public market price. Caplight tracks Amplexd Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Amplexd Therapeutics worth (valuation)?

Valuation information for Amplexd Therapeutics is not publicly available.

Can I buy Amplexd Therapeutics stock?

Amplexd Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Amplexd Therapeutics's last funding round?

Amplexd Therapeutics's most recent funding round was Seed on May 20, 2024.

Who are the main investors in Amplexd Therapeutics?

Investor information for Amplexd Therapeutics is not publicly disclosed.

Will Amplexd Therapeutics IPO soon?

No public IPO plans have been announced for Amplexd Therapeutics.

How can I track Amplexd Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Amplexd Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersGaithersburg, Maryland
Employee Range2
Year Founded2022
Last FundingMay 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?